Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15
Contact your PlexusDx-affiliated compounding pharmacy immediately for guidance on whether the dose should be discarded and replaced
By Lana Pine | Published on December 17, 2025 4 min read A large real-world study published in Neurology found that people with Type 2 diabetes taking glucagon-like peptide-1 (GLP-1) receptor agonists had a lower risk of developing epilepsy than those taking dipeptidyl peptidase-4 (DPP-4) inhibitors
Alkhalifa, A
%203_2.webp?width=1600&height=1067&name=Janumet%20(sitagliptin_metformin)%203_2.webp)
Your blood sugar and metabolism are recalibrating GLP-1s help improve insulin sensitivity and change how glucose moves into your cells
Your provider will guide you to the best plan based on your goals
Emerging research suggests these drugs may possess anti-inflammatory properties beyond their established metabolic effects
US$ 25.22
US$ 20.11
US$ 29.39
US$ 25.11
